The global control and prevention of cervical cancer caused by HPV
The global control and prevention of cervical cancer caused by HPV
Ganetespib in first-line treatment of women with metastatic HER2 positive or triple negative breast cancer
The 1st Immunotherapy of Cancer Conference (ITOC)
Molecular pathways associated with immune modulation and thalidomide analogues
Cost constraints affect treatment decision-making in China and Singapore - expert discussion
ecancermedicalscience Editor's Choice for January 2014
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Critical insights on leukaemia and lymphoma from ASH 2013
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer
Dissecting the biology of the androgen receptor pathway